For a complete CV download here


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

For a complete CV download here

  1. 1. Office Northside Cardiology, P.C. 5670 Peachtree Dunwoody Road NE Suite 880 Atlanta, GA 30342 office phone (404) 256-2525 pager (404) 278-8315 mobile (678)-612-2576 L. Van-Thomas Crisco, MD Current Employment Partner, Northside Cardiology, P.C., a seven-person private practice group providing interventional and general cardiovascular consultative services at Northside Hospital-Sandy Springs, Northside Hospital-Forsyth, and St. Joseph’s Hospital in Atlanta, GA (9/5/2000-present). Percutaneous Coronary and Peripheral Intervention § Complex Coronary and Cardiac Intervention § Peripheral and Craniocervical Arterial Angiography and Intervention § Radial Artery Access Diagnostic and Interventional Catheterization General Cardiology Services § Echocardiography (TTE, Stress, DSE, TEE) § Doppler carotid ultrasound arterial imaging § ETT/ non-nuclear § Arrhythmia management § CHF: acute and chronic § Acute Care Specialist Appointments Medical Director of Cardiology and Cardiac Rehabilitation Services, Northside Hospital, Atlanta, GA, 3/1/02- present, actively managing equipment, facilities, personnel and programs necessary to provide excellence in cardiovascular care and service at Northside Hospital. Professional Training Interventional Cardiology Fellow, Andreas Gruentzig Cardiovascular Center, Emory University Interventional Cardiology, Atlanta, GA. 7/1999-7/2000. Director of Interventional Cardiology: John S. Douglas, Jr. M.D., Emory University Cardiology, Suite 4C, 1365 Clifton Rd., NE, Atlanta, GA 30322 Clinical Cardiology Fellow, Emory University Cardiology, Atlanta, GA, 7/1997-7/1999. Fellowship Program Director: Robert W. Taylor, M.D., Ph.D., WMB 319, 1639 Pierce Dr., NE, Atlanta, GA 30322 Basic Science Molecular Cardiology Research Fellow, Emory University Cardiology, Atlanta, GA, 7/1994-7/1997. Endothelial Cell Gene Regulation Research: Ets and NF-kB redox-sensitive activation mechanisms . Fellowship Program Director: Robert W. Taylor, M.D., Ph.D., WMB 319, 1639 Pierce Dr., NE,
  2. 2. Atlanta, GA 30322 Internship and Residency Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 1991-1994 § Bronze Beeper Award for Student Teaching 1993-1994 Medical Degree University of North Carolina , Chapel Hill, NC, 1987- 1991 § MD degree Post-graduate Research Johns Hopkins University, Baltimore, MD, 1986-1987 § Dept. Of Immunology, research assistant to Dr. Kimishige Ishizaka. T- cell antigen presentation and processing. College Wake Forest University, Winston-Salem, NC, 1982-1986 § Cum Laude, BS Chemistry, Minor Philosophy Personal Personal interests include golf, trout fishing, diving. Memberships Fellow, American College of Cardiology Fellow, Society for Cardiac Angiography and Interventions American Heart Association, Council on Clinical Cardiology American College of Physicians/Amer. Soc. of Internal Med., Member Medical Licensure Georgia #038457 Certification American Board of Internal Medicine-Interventional Cardiology (11/8/00), Cardiology (11/3/99), and Internal Medicine (8/94). Basic Life Support (Exp. 1/10/05) Advanced Cardiac Life Support (Exp. 1/10/05) Publications L. Van-Thomas Crisco. Stable Angina Pectoris in The AHA Clinical Cardiac Consult, Joseph S. Alpert, MD. editor, Lippincott –Williams- Wilkins, 2000. L. Van-Thomas Crisco and Douglas C. Morris. Interventional Cardiology Update, in Society for Cardiac Anesthesiologists Update 2000 Monograph, Jack Shanewise, MD, editor, Lippincott –Williams- Wilkins, 2001.
  3. 3. William S. Weintraub, Stephen D. Clements, Jr, L. Van-Thomas Crisco, Robert A. Guyton, Joseph M. Craver, Ellis L. Jones, and Charles R. Hatcher, Jr. Twenty-Year Survival After Coronary Artery Surgery: An Institutional Perspective From Emory University, Circulation 107: 1271-1277, 2003. Presentations Thalidomide Fails to Inhibit Adventitial Angiogenesis and Restenosis in the Swine Model of Balloon Overstretch Injury. L. Van-Thomas Crisco, MD. Poster Presentation at the Keystone Symposium: Cellular and Molecular Regulation of Angiogenesis and Vasculogenesis, Salt Lake City, UT, March, 2000. 20-Year Survival After Coronary Artery Surgery: An Institutional Perspective From Emory University. L. Van-Thomas Crisco, MD Presented orally at the American Heart Association Scientific Sessions 72nd Annual Scientific Sessions, Atlanta, GA November 1999. Endothelial cell Ets-dependent gene expression is redox-sensitive. L. Van-Thomas Crisco, MD Presented in poster format at the American Heart Association Conference on Structure and Function of the Vascular Wall, Santé Fe, NM February 1996. NF-kB-dependent VCAM-1 promoter activation by TNF-a and linoleic acid is inhibited by PDTC via a redox-sensitive mechanism. Presented in poster format at the American Heart Association Conference on Structure and Function of the Vascular Wall, Snowbird, UT February 1995. Research Experience As Principal Investigator EVENT REGISTRY: A Multicenter Registry for the Evaluation of Drug Eluting Stents and Ischemic Events Closure I: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System versus Best Medical Therapy in Patients with a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through A Patent Foramen Ovale ACRI Patient Registry: Medical Use of Anticoagulants in the Community Hospital Setting…a 5000 Patient Registry As Sub-Investigator Deliver: A Prospective, Randomized, Single-Blinded, Parallel-Group (Two-Arm), Multi-Center, Clinical Evaluation of The RX Achieve™ Drug-Coated Coronary Stent System in the Treatment of Patients with De Novo Native Coronary Artery Lesions - The Deliver Trial #01-345 ADEST: Protocol #TMC-BIV-03-02; Clinical Evaluation of the Concomitant use of Bivalirudin (Angiomax®) and a Drug-Eluting Stent (Retired 6/24/04)
  4. 4. Berlex: A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5fgf-4 in Patients with Stable Angina; Berlex Protocol #304386 Research Experience As Sub-Investigator (cont) SIROLIMUS: An Evaluation of the Sirolomus-Coated BX Velocity™ Balloon- Expandable Stent in the Treatment of Patients with In-Stent Restenotic of Native Coronary Artery Lesions; Protocol #ACRI 01-01(Retired 4/28/05) The TheraP Trial: A Safety and Feasibility Study of the use of the TheraSource™ Intravascular Brachytherapy System for Prevention of Restenosis Following Successful Percutaneous Transluminal Angioplasty (PTA) in Superficial Femoral and Popliteal Arteries (Retired 4/20/05) TAXUS V: De Novo Lesions; A Randomized, Double-Blind Trial to Assess TAXUS™ Paclitaxel-Eluting Coronary Stents, Slow-Release Formulation, in the Treatment of De Novo Coronary Lesions SISR: A Multi-Center, Randomized, Study of the Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent vs. Intravascular Brachytherapy in the Treatment of Patients with In-Stent Restenotic Coronary Artery Lesions MyoHeart: A Phase I, Open-Label, Non-Randomized, Dose Escalation, Multi-Center Study to Assess the Safety and Cardiovascular Effects of Autologous Skeletal Myoblast (Myocell™) Implantation by a Transendocardial Catheter Delivery System (MyoCath™) in Congestive Heart Failure Patients Post Mycardial Infarction(s) with Previous Placement of an Implantable Cardioverter Defibrillator (MYOHEART™) Endeavor IV: A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Taxus™ Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions TRANSCENDENCE-PCI: A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety of SCH 530348 in Subjects Undergoing Non- Urgent Percutaneous Coronary Intervention (TRANSCENDENCE-PCI)